EPS创健科技：截至二零二五年九月三十日止六个月之中期业绩公告

3860 223.92.6522,177,4190.78 EPS 9(0.78)2.83 1. EPS34 2. 21 3. IROCRO 4. (a)(b)(c)IROCROIROCRO 4. (2,497)6,9119255,339 19,302 4. 4. IROCRO 10% –148,41925,294N/A* AB *10% 5. 6. 6. 28.25%216.5%16.5% 25% 34.59% 7. 1.05,221,774 8. 9. 3090IROCRO60120IROCRO180 1303160619090 1303160619090 (IRO)(CRO) HCP R&E65%R&E EPEPTR100%EPTR IROCRO IRO IROCROCRO EPS Innovative Medicine (Hong Kong) LimitedEPS Innovative HCP73.428.338.6%101.7 IROCRO IROCRO28.516.959.2%45.4CRO 83.0%86.9% 0.62.9 (i)(ii)(iii)(iv)(v) 245.076.9168.168.6% 212.863.8149.070.0%2.60.583.1130.1 27.813.114.752.9%0.30.1104.6176.9 4.3 15.519.223.9% IROCRO 3.05.6IRO 15.528.445.4%11.6%20.2% 29.73.226.5(i)(ii) 7.4EPS Innovative 20.213.931.2% 27.624.511.2%IRO 4.73.6 2.810.513.3(i)(ii)(iii) 0.782.83 70.7151.5118.7135.72.91.49.0%126.8% 0.030.0426.57.893.6% 3090 5.2522,177,4190.01 5% 4,0004,000 12313921.326.5 IROCRO CROCROIRO C1 C.2.1C.2.1 C3 3.213.23D.3 EPS